Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Nektar Therapeutics’s stock clocked out at $1.00, down -5.66% from its previous closing price of $1.06. In other words, the price has decreased by -$5.66 from its previous closing price. On the day, 3.4 million shares were traded.
Ratios:
To gain a deeper understanding of NKTR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.24 and its Current Ratio is at 4.24. In the meantime, Its Debt-to-Equity ratio is 4.22 whereas as Long-Term Debt/Eq ratio is at 3.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, B. Riley Securities on January 08, 2025, initiated with a Buy rating and assigned the stock a target price of $4.
On December 10, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $6.50.
On November 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $7.Piper Sandler initiated its Overweight rating on November 04, 2024, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 19 ’25 when Wilson Mark Andrew bought 11,040 shares for $1.01 per share.
ROBIN HOWARD W bought 23,774 shares of NKTR for $23,983 on Feb 19 ’25. On Feb 19 ’25, another insider, Zalevsky Jonathan, who serves as the Officer of the company, bought 10,300 shares for $1.01 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.98 while its Price-to-Book (P/B) ratio in mrq is 3.77.
Stock Price History:
Over the past 52 weeks, NKTR has reached a high of $1.93, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is 8.17%, while the 200-Day Moving Average is calculated to be -17.64%.
Shares Statistics:
A total of 184.46M shares are outstanding, with a floating share count of 177.54M. Insiders hold about 3.75% of the company’s shares, while institutions hold 70.02% stake in the company.
